Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Arthritis and Rheumatism|December 1, 1994
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein responseC Gabay, F Gay-Croisier, P Roux-Lombard, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Age and Ageing|May 1, 1996
Quantitative and qualitative alterations of acute-phase proteins in healthy elderly personsS P Ballou, F B Lozanski, S Hodder, et al.
Nature|November 9, 2001
Asynchronous replication and allelic exclusion in the immune systemR Mostoslavsky, N Singh, T Tenzen, et al.
Molecular Medicine (Cambridge, Mass.)|November 7, 1999
Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shockS R Grobmyer, R C Armstrong, S C Nicholson, et al.
RMD Open|May 10, 2020
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in SwitzerlandA Finckh, C Tellenbach, L Herzog, et al.
Vaccine|January 9, 2020
Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individualsJ Burkhard, A Ciurea, C Gabay, et al.
Scandinavian Journal of Rheumatology|September 28, 2018
Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaborationK Chatzidionysiou, G Lukina, C Gabay, et al.
Clinical and Experimental Immunology|December 25, 2015
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's diseaseM-A Boutet, G Bart, M Penhoat, et al.
Pageof 18